These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7653320)

  • 1. The relationship of counselor and peer alliance to drug use and HIV risk behaviors in a six-month methadone detoxification program.
    Tunis SL; Delucchi KL; Schwartz K; Banys P; Sees KL
    Addict Behav; 1995; 20(3):395-405. PubMed ID: 7653320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.
    Sees KL; Delucchi KL; Masson C; Rosen A; Clark HW; Robillard H; Banys P; Hall SM
    JAMA; 2000 Mar; 283(10):1303-10. PubMed ID: 10714729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in HIV risk behavior among injecting drug users: the impact of 21 versus 90 days of methadone detoxification.
    Iguchi MY; Bux DA; Lidz V; French JF; Baxter RC; Platt JJ
    AIDS; 1996 Dec; 10(14):1719-28. PubMed ID: 8970693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiles of self-reported HIV-risk behaviors among injection drug users in methadone maintenance treatment, detoxification, and needle exchange programs.
    Mark HD; Nanda J; Davis-Vogel A; Navaline H; Scotti R; Wickrema R; Metzger D; Sochalski J
    Public Health Nurs; 2006; 23(1):11-9. PubMed ID: 16460416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of an AIDS prevention program for methadone patients.
    Magura S; Siddiqi Q; Shapiro J; Grossman JI; Lipton DS; Marion IJ; Weisenfeld L; Amann KR; Koger J
    Int J Addict; 1991 Jun; 26(6):629-55. PubMed ID: 1757169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of antiretroviral therapy on drug-using and high risk sexual behaviors among HIV-positive methadone maintenance treatment clients: a qualitative study].
    Qian X; Cao X; Zhao Y; Jin Y; Willa D; Luo W; Wang C; Rou K; Zhang B; Duan S; Tang R; Wu Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Jan; 36(1):49-51. PubMed ID: 25876865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-efficacy and illicit opioid use in a 180-day methadone detoxification treatment.
    Reilly PM; Sees KL; Shopshire MS; Hall SM; Delucchi KL; Tusel DJ; Banys P; Clark HW; Piotrowski NA
    J Consult Clin Psychol; 1995 Feb; 63(1):158-62. PubMed ID: 7896984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of HIV infection in the methadone program. A study of a drop-in clinic in Zurich].
    Huber-Stemich F; Haas H
    Schweiz Rundsch Med Prax; 1990 Sep; 79(36):1017-21. PubMed ID: 2218224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of HIV testing and high-risk behaviors among clients in methadone maintenance treatment.
    Grella CE; Campos M; Anglin MD
    AIDS Educ Prev; 1998 Oct; 10(5):403-16. PubMed ID: 9799937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost.
    Avants SK; Margolin A; Sindelar JL; Rounsaville BJ; Schottenfeld R; Stine S; Cooney NL; Rosenheck RA; Li SH; Kosten TR
    Am J Psychiatry; 1999 Jan; 156(1):27-33. PubMed ID: 9892294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Participation in an outreach-based coupon distribution program for free methadone detoxification.
    Bux DA; Iguchi MY; Lidz V; Baxter RC; Platt JJ
    Hosp Community Psychiatry; 1993 Nov; 44(11):1066-72. PubMed ID: 8288175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of methadone maintenance treatment on HIV risk behaviors of heroin drug users].
    Liu EW; Liang T; Shen LM; Zhong H; Wang B; Wu ZY; Detels R
    Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Nov; 44(11):981-4. PubMed ID: 21215123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the helping alliance and its impact in the treatment of opiate dependence.
    Belding MA; Iguchi MY; Morral AR; McLellan AT
    Drug Alcohol Depend; 1997 Oct; 48(1):51-9. PubMed ID: 9330921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cognitive-existential analysis of counselor responses to HIV-positive substance misusers in an outpatient methadone program and a residential therapeutic community.
    Capone CT; Melchionda R; DeRovira N; Katowsky K; Condren R; Peterson M
    Int J Addict; 1992 May; 27(5):587-611. PubMed ID: 1318275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychoeducational group approach: HIV risk reduction in drug users.
    Sorensen JL; London J; Heitzmann C; Gibson DR; Morales ES; Dumontet R; Acree M
    AIDS Educ Prev; 1994 Apr; 6(2):95-112. PubMed ID: 8018443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled trial of prescribed heroin in the treatment of opioid addiction.
    March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
    J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A peer-led mobile outreach program and increased utilization of detoxification and residential drug treatment among female sex workers who use drugs in a Canadian setting.
    Deering KN; Kerr T; Tyndall MW; Montaner JS; Gibson K; Irons L; Shannon K
    Drug Alcohol Depend; 2011 Jan; 113(1):46-54. PubMed ID: 20727683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in HIV risk behaviors among cocaine-using methadone patients.
    Magura S; Rosenblum A; Rodriguez EM
    J Addict Dis; 1998; 17(4):71-90. PubMed ID: 9848033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users.
    Williams AB; McNelly EA; Williams AE; D'Aquila RT
    AIDS Care; 1992; 4(1):35-41. PubMed ID: 1314099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of psychiatric comorbidity on HIV risk behaviors: changes during drug abuse treatment.
    King VL; Kidorf MS; Stoller KB; Brooner RK
    J Addict Dis; 2000; 19(4):65-83. PubMed ID: 11110066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.